WIERENGA WENDALL — SEC Form 4 filings
SEC reporting owner CIK 1235945. 13 Form 4 filings on record with FilingPulse; latest filed 2025-07-16.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-05-16 to 2025-07-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 25,936 shares, $1,074,986 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 20,000 shares @ $38.46 ($769,200) in CYTOKINETICS INC, filed 2025-04-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CYTOKINETICS INC (CYTK) | Director | 11 | — | 4 legs · 25,936 sh · $1,074,986 | 17 |
| Crinetics Pharmaceuticals, Inc. (CRNX) | Director | 2 | — | — | 4 |
Form 4 filings — WIERENGA WENDALL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 164 @ $38.01 | EDGAR |
| 2025-06-13 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 6,900 @ $0 · Grant/award (A): 10,350 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 7,333 @ $0 · Grant/award (A): 10,880 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 20,000 @ $6.21 · Sale (S): 20,000 @ $38.46 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 162 @ $38.56 | EDGAR |
| 2025-01-06 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 127 @ $48.93 | EDGAR |
| 2024-12-16 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 742 @ $7.37 · Sale (S): 742 @ $48.61 · Option exercise (M): 742 (derivative) @ $0 | EDGAR |
| 2024-11-26 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 742 @ $7.37 · Sale (S): 742 @ $50 · Option exercise (M): 742 (derivative) @ $0 | EDGAR |
| 2024-10-31 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 4,452 @ $7.37 · Sale (S): 4,452 @ $52.25 · Option exercise (M): 4,452 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 118 @ $52.60 | EDGAR |
| 2024-07-03 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 114 @ $0 | EDGAR |
| 2024-06-11 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 3,400 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 5,600 @ $0 · Grant/award (A): 3,636 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1235945 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →